医学
膀胱癌
免疫疗法
癌症
肿瘤科
化疗
靶向治疗
膀胱癌
内科学
重症监护医学
作者
Jian Huang,X Chen,Lin Tx
出处
期刊:PubMed
日期:2016-10-01
卷期号:54 (10): 734-737
被引量:1
标识
DOI:10.3760/cma.j.issn.0529-5815.2016.10.002
摘要
Bladder cancer is one of the most common malignant tumors of the urinary system in China, but it is still difficult to be accurate in the diagnosis and treatment. The rapid development of high-throughput sequencing technology and data analysis of biological information pushes the medicine to enter into the precise times. In the review, the recent progress of molecular subtype, assessment of immune and metastatic status, efficacy prediction of chemotherapy, immunotherapy and targeted therapy are summarized. It provides new ideas and methods for accurate diagnosis and treatment of bladder cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI